NPI: 1770554214 · EMPORIA, VA 23847 · General Acute Care Hospital · NPI assigned 02/01/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 02/01/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 35,327 | $702K |
| 2019 | 43,322 | $1.03M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,756 | 6,318 | $604K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,998 | 2,365 | $224K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,627 | 1,415 | $115K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,252 | 1,138 | $101K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,037 | 684 | $100K |
| 70450 | Computed tomography, head or brain; without contrast material | 970 | 724 | $98K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,589 | 1,177 | $95K |
| 96361 | Intravenous infusion, hydration; each additional hour | 734 | 605 | $75K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,057 | 474 | $62K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,578 | 980 | $58K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 373 | 294 | $54K |
| 36415 | Collection of venous blood by venipuncture | 5,868 | 3,834 | $21K |
| G0378 | Hospital observation service, per hour | 218 | 148 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 378 | 350 | $11K |
| 80053 | Comprehensive metabolic panel | 3,509 | 2,489 | $11K |
| 97161 | 444 | 345 | $8K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 37 | 31 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,042 | 1,452 | $6K |
| 86756 | 443 | 415 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | 657 | 541 | $5K |
| 87430 | 1,235 | 1,111 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 16 | 12 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 696 | 493 | $4K |
| 81025 | 1,281 | 1,042 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,327 | 3,574 | $4K |
| J3490 | Unclassified drugs | 4,330 | 1,752 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 49 | 39 | $3K |
| 71045 | Radiologic examination, chest; single view | 2,145 | 1,549 | $3K |
| 84484 | 2,068 | 1,222 | $3K | |
| 81001 | 3,440 | 2,625 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,924 | 1,674 | $2K |
| 83880 | 768 | 537 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | 559 | 381 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,192 | 925 | $2K |
| 87040 | 293 | 179 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 14 | 12 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,451 | 1,721 | $1K |
| 73564 | 93 | 77 | $1K | |
| 82962 | 856 | 559 | $1K | |
| 83605 | 470 | 315 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,814 | 1,393 | $714.53 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,935 | 1,511 | $712.64 |
| 97016 | 68 | 25 | $687.32 | |
| 80320 | 200 | 135 | $587.34 | |
| 80061 | Lipid panel | 71 | 41 | $521.37 |
| 83735 | 1,184 | 800 | $496.70 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 934 | 737 | $437.89 |
| 73630 | 51 | 44 | $400.54 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 680 | 514 | $381.76 |
| 85610 | 1,324 | 958 | $335.13 | |
| 73130 | 41 | 38 | $306.45 | |
| 83874 | 92 | 62 | $248.68 | |
| 83690 | 643 | 511 | $242.33 | |
| 85730 | 1,216 | 907 | $229.71 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 14 | 13 | $220.88 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 18 | 12 | $215.02 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 492 | 402 | $192.75 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 173 | 125 | $181.60 |
| 85027 | 58 | 50 | $156.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 94 | 65 | $95.56 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 19 | 12 | $78.12 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 20 | 15 | $73.03 |
| 73610 | 17 | 16 | $57.42 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 342 | 251 | $30.89 |
| 82553 | 19 | 12 | $17.98 | |
| 82150 | 48 | 40 | $16.01 | |
| 84702 | 13 | 12 | $14.85 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 145 | 100 | $13.22 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 132 | 111 | $10.70 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14 | 13 | $10.46 |
| 87186 | 38 | 24 | $9.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 111 | 83 | $9.36 |
| 87077 | 92 | 63 | $9.33 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 59 | 43 | $6.63 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 35 | 27 | $2.60 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 14 | 12 | $1.65 |
| J1940 | Injection, furosemide, up to 20 mg | 18 | 12 | $0.46 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 194 | 149 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 28 | 26 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 18 | 12 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 270 | 225 | $0.00 |
| 96376 | 73 | 65 | $0.00 | |
| 82550 | 41 | 26 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 13 | 13 | $0.00 |